Tatiana V. Karpinets

Tatiana V. Karpinets

Auto-generated profile, based on publicly available information

Tatiana V. Karpinets

The University of Texas MD Anderson Cancer Center, Houston, TX

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2018 in Science
Verified
Journal Article
Closed access
PDF file
VGVancheswaran Gopalakrishnan
Vancheswaran Gopalakrishnan
CSC. N. Spencer
C. N. Spencer
LNLuigi Nezi
Luigi Nezi
Alexandre ReubenAlexandre Reuben
Alexandre Reuben
MAMiles C. Andrews
Miles C. Andrews
JWJennifer A. Wargo
Jennifer A. Wargo
Good bacteria help fight cancer: Resident gut bacteria can affect patient responses to cancer immunotherapy (see the Perspective by Jobin). Routy et al. show that antibiotic consumption is associated with poor response to immunotherapeutic PD-1 blockade. They profiled samples from patients with lung and kidney cancers and found that nonresponding patients had low levels of the bacterium Akkermansia muciniphila . Oral supplementation of the bacteria to antibiotic-treated mice restored the response to immunotherapy. Matson et al. and Gopalakrishnan et al. studied melanoma patients receiving PD-1 blockade and found a greater abundance of “good” bacteria in the guts of responding patients. Nonresponders had an imbalance in gut flora composition, which correlated with impaired immune cell activity. Thus, maintaining healthy gut flora could help patients combat cancer. Science , this issue p. 91 , p. 104 , p. 97 ; see also p. 32

1 March 2017 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
VGVancheswaran Gopalakrishnan
Vancheswaran Gopalakrishnan
CSChristine Spencer
Christine Spencer
Alexandre ReubenAlexandre Reuben
Alexandre Reuben
TKTatiana Karpinets
Tatiana Karpinets
DHDiane Hutchinson
Diane Hutchinson
JWJennifer A. Wargo
Jennifer A. Wargo
2 Background: Tremendous advances have been made in cancer therapy through the use of immune checkpoint blockade, although responses are not always durable. There is a growing appreciation of the role of the microbiome in cancer-related outcomes and recent evidence in murine models suggests that modulation of the gut microbiome may enhance responses to immune checkpoint blockade in melanoma. However this has not been investigated in patients. Here, we demonstrate that differential bacterial “signatures” exist in the gut microbiome of responders (R) and non-responders (NR) to anti-PD1 therapy at baseline, and that insights gained could be used to derive actionable strategies to enhance responses. Methods: We collected oral (n = 222) and gut microbiome (n = 113) samples on a large cohort of patients with metastatic melanoma (n = 228), with a majority treated with anti-PD1 therapy (n = 110). Patients were classified as either R or NR based on RECIST criteria, and 16S rRNA gene sequencing was performed to characterize the diversity and composition of the microbiomes. Immune profiling (via 7-marker IHC panel of CD3, CD8, PD-1, PD-L1, Granzyme B, RORγT and FoxP3) was performed in available tumors at baseline. Results: In these studies, we observed significant differences in the diversity and composition of the gut microbiome in R versus NR to PD1 blockade at baseline, but no clear differences in oral microbiomes. Specifically, R had a significantly higher alpha diversity compared to NR (p = 0.017). Notable differences were also seen in the composition of the gut microbiome of R versus NR. Immune profiling demonstrated significantly increased immune infiltrates in baseline tumor samples of R, with a positive correlation between CD8, CD3, PD1 and FoxP3 T-cell density and abundance of specific bacteria enriched in R (e.g. Faecalibacterium). Conclusions: Differences exist in the diversity and composition of the gut microbiome in R vs NR to anti-PD1 therapy. These results have far-reaching implications and suggest that modifications to the gut microbiome could potentially enhance therapeutic responses to immune checkpoint blockade.

16 September 2026 in Oral Oncology
Verified
Journal Article
Closed access
TKTatiana V. Karpinets
Tatiana V. Karpinets
YMYoshitsugu Mitani
Yoshitsugu Mitani
MSMichael T Spiotto
Michael T Spiotto
JLJie Li
Jie Li
XSXingzhi Song
Xingzhi Song
AEAdel K. El-Naggar
Adel K. El-Naggar

15 April 2020 in Cancer Research
Verified
Journal Article
Closed access
GBGreyson Biegert
Greyson Biegert
XWXiaogang Wu
Xiaogang Wu
TKTatiana V. Karpinets
Tatiana V. Karpinets
Melissa P. MezzariMelissa P. Mezzari
Melissa P. Mezzari
JZJinhua Zhang
Jinhua Zhang
AKAnn Klopp
Ann Klopp
Introduction: 16S RNA sequencing and whole-genome sequencing (WGS) techniques have been previously shown to have a significant degree of correlation, particularly for higher-order-level taxa. However, the large majority of those studies utilize data derived from samples collected in similar but not identical contexts. This project provides a unique opportunity in that both 16S RNA and WGS sequencing datasets were derived from a single fecal sample originating from each patient while undergoing chemoradiation therapy. Using this high-quality information, we investigated the correlation of these two datasets in terms of microbial composition and taxa abundances. Methods: Forty-one rectal swab samples were collected at the time of pelvic examination before the initiation of chemoradiation treatment and sequenced via Illumina platforms. Alpha and beta diversity was evaluated using PCoA ordination derived from several distance metrics (Bray-Curtis, Jaccard, Weighted and Unweighted UniFrac, and Euclidean). Diversity measures from different data analysis tools were also compared to highlight differences in data processing. Taxa with the highest relative abundances within each set of sequencing data were used to evaluate consensus between the datasets. Results: Alpha diversity assessed by different measures from WGS analysis correlated (Spearman rho value) with the same measures derived from 16S rRNA sequencing. These measures include OTU abundances (rho = 0.763, p = 6.61e−09), Shannon diversity (rho = 0.809, p = 4.40e−09), and InvSimpson (rho = 0.797, p = 2.11e−08). Beta diversity analysis highlighted a greater level of similarity within WGS samples than 16sRNA samples and a high degree of dissimilarity between the two datasets. Among the top fourteen most abundant taxa identified in 16S rRNA sequencing, the four best correlated with WGS results were Faecalibacterium, rho = 0.475, p = 1.68e−03; Mollicutes, rho = 0.302, p = 5.48e−02; Clostridiales, rho = 0.021, p = 8.98e−01; and Bacteria, rho = 0.016, p = 9.23e−01. The remaining ten taxa were negatively correlated. Conclusions: The use of whole-genome sequencing approaches in microbiome analysis is expanding in order to provide greater depth of information about microbial function. However, comparisons of results from 16S rRNA sequencing and WGS will need to be evaluated with caution due to differences in the interpretation of relative abundances of specific taxa. Future efforts may help to better harmonize these analyses to facilitate comparisons across platforms. Citation Format: Greyson Biegert, Xiaogang Wu, Tatiana V. Karpinets, Melissa Mezzari, Jianhua Zhang, Lauren Colbert, Ann Klopp. Comparisons of microbial composition identified via 16s rRNA sequencing and whole-genome sequence-based analysis using gut samples for patients with cervical cancer [abstract]. In: Proceedings of the AACR Special Conference on the Microbiome, Viruses, and Cancer; 2020 Feb 21-24; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2020;80(8 Suppl):Abstract nr B11.

3 April 2023
Verified
Other
Open access
TKTatiana V. Karpinets
Tatiana V. Karpinets
TSTravis N. Solley
Travis N. Solley
MMMegan D. Mikkelson
Megan D. Mikkelson
SDStephanie Dorta-Estremera
Stephanie Dorta-Estremera
SNSita S. Nookala
Sita S. Nookala
AKAnn Klopp
Ann Klopp

3 April 2023
Verified
Other
Open access
TKTatiana V. Karpinets
Tatiana V. Karpinets
TSTravis N. Solley
Travis N. Solley
MMMegan D. Mikkelson
Megan D. Mikkelson
SDStephanie Dorta-Estremera
Stephanie Dorta-Estremera
SNSita S. Nookala
Sita S. Nookala
AKAnn Klopp
Ann Klopp